Quick Heal Tech Standalone March 2022 Net Sales at Rs 103.75 crore, down 2.22% Y-o-Y
NULL06-05-2022
Quick Heal Technologies Ltd - 539678 - Board Meeting Outcome for Outcome Of The Board Meeting
We wish to inform you that the Board of Directors at its meeting held on May 05, 2022 through video conferencing has approved the Audited Financial Results of the Company for the financial year ended March 31, 2022, both Standalone and consolidated.05-05-2022
Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Earnings Call for Q4FY22 Results02-05-2022
Quick Heal Technologies Ltd - 539678 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Quick Heal Technologies Limited has made allotment of 675 Equity Shares under ESOP.02-05-2022
Quick Heal Technologies Ltd - 539678 - Board to consider Dividend
Quick Heal Technologies Ltd has informed BSE that a Board Meeting of the Company is scheduled to be held on May 05, 2022, to consider and approve inter alia, the following business:1. Consider and approve the Audited Financial Results of the Company (Standalone as well as Consolidated) for the quarter ended March 31, 2022 and Annual Financial Statements (Standalone as well as Consolidated) for the financial year ended March 31, 2022;2. Consider recommendation of Dividend, on equity shares, if any, for the financial year ended March 31, 2022, subject to approval of the shareholders.Further, in terms of the Company''s Code of Conduct for Prevention of Insider Trading in securities of the Company, the trading window close period has commenced from April 01, 2022 and will end 48 hours after the financial results are made public on May 05, 2022.29-04-2022
Quick Heal Technologies Ltd - 539678 - Board Meeting Intimation for Approval Of Audited Financial Results For The Year Ended March 31, 2022
Quick Heal Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/05/2022 ,inter alia, to consider and approve the Audited Financial Results of the Company (Standalone as well as Consolidated) for the quarter ended March 31, 2022 and Annual Financial Statements (Standalone as well as Consolidated) for the financial year ended March 31, 2022 and to consider recommendation of Dividend, on equity shares, if any, for the financial year ended March 31, 2022, subject to approval of the shareholders.29-04-2022
Quick Heal Technologies Ltd - 539678 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayQuick Heal Technologies Ltd 2CINL72200MH1995PLC091408 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: A Srinivasa Rao Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: Navin Sharma Designation: Chief Financial Officer EmailId: [email protected] Date: 29/04/2022 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.29-04-2022
Quick Heal Technologies Ltd - 539678 - Compliance Certificate For Share Transfer Audit In Terms Of Regulation 40(9) Of SEBI(Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 31.03.2022
Compliance Certificate For Share Transfer Audit In Terms Of Regulation 40(9) Of SEBI(Listing Obligations And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 31.03.202213-04-2022
Quick Heal Technologies Ltd - 539678 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Kailash KatkarDesignation :- Chief Executive Officer11-04-2022